'Ryanopathy': Causes and manifestations of RyR2 dysfunction in heart failure

Cardiovascular Research

Volumn 98, Issue 2, 2013, Pages 240-247

  Belevych, Andriy E ^a   Radwański, Przemysław B ^a   Carnes, Cynthia A ^a,b   Györke, Sandor ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Arrhythmia; Ca2+ release; Heart failure; Ryanodine receptor; Sarcoplasmic reticulum

Indexed keywords

REACTIVE OXYGEN METABOLITE; RYANODINE RECEPTOR 2; XANTHINE OXIDASE;

ADRENERGIC STIMULATION; ARRHYTHMOGENESIS; AUTOREGULATION; BINDING AFFINITY; CALCIUM SIGNALING; CARDIOVASCULAR MORTALITY; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CYTOSOL; ENZYME INHIBITION; GENE MUTATION; GENE OVEREXPRESSION; HEART DEPOLARIZATION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE POTENTIAL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INOTROPISM; LIPID BILAYER; MORBIDITY; NITROSYLATION; NONHUMAN; NONISCHEMIC CARDIOMYOPATHY; OXIDATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; RYANOPATHY; STEADY STATE;

ANIMALS; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CALSEQUESTRIN; EXCITATION CONTRACTION COUPLING; HEART FAILURE; HUMANS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 84877256978     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt024     Document Type: Review

References (80)

1. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol 1983;245:C1-C14.
2. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht, Boston: Kluwer Academic Publishers; 2001.
3. Cheng H, Lederer WJ. Calcium sparks. Physiol Rev 2008;88:1491-1545.
4. Li P, Chen SR. Molecular basis of Ca2+ activation of the mouse cardiac Ca2+ release channel (ryanodine receptor). J Gen Physiol 2001;118:33-44.
5. Cheng H, Lederer MR, Lederer WJ, Cannell MB. Calcium sparks and [Ca2+]i waves in cardiac myocytes. Am J Physiol 1996;270:C148-C159.
6. Radwanski PB, Belevych AE, Brunello L, Carnes CA, Gyorke S. Store-dependent deactivation: cooling the chain-reaction of myocardial calcium signaling. J Mol Cell Cardiol. Advance Access published October 27, 2012, doi: 10.1016/j.yjmcc.2012.10.008.
7. Terentyev D, Viatchenko-Karpinski S, Valdivia HH, Escobar AL, Gyorke S. Luminal Ca2+ controls termination and refractory behavior of Ca2+-induced Ca2+ release in cardiac myocytes. Circ Res 2002;91:414-420.
8. Szentesi P, Pignier C, Egger M, Kranias EG, Niggli E. Sarcoplasmic reticulum Ca2+ refilling controls recovery from Ca2+-induced Ca2+ release refractoriness in heart muscle. Circ Res 2004;95:807-813.
9. Sobie EA, Dilly KW, dos Santos Cruz J, Lederer WJ, Jafri MS. Termination of cardiac Ca2+ sparks: an investigative mathematical model of calcium-induced calcium release. Biophys J 2002;83:59-78.
10. Gyorke S, Terentyev D. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. Cardiovasc Res 2008;77:245-255.
11. Meissner G. Regulation of mammalian ryanodine receptors. Front Biosci 2002;7: d2072-d2080.
12. Wehrens XH, Lehnart SE, Marks AR. Intracellular calcium release and cardiac disease. Annu Rev Physiol 2005;67:69-98.
13. Xiao B, Zhong G, Obayashi M, Yang D, Chen K, Walsh MP et al. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts. Biochem J 2006;396:7-16.
14. Valdivia HH. Ryanodine receptor phosphorylation and heart failure: phasing out S2808 and "criminalizing" S2814. Circ Res 2012;110:1398-1402.
15. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000;101:365-376.
16. Currie S, Loughrey CM, Craig MA, Smith GL. Calcium/calmodulin-dependent protein kinase IId associates with the ryanodine receptor complex and regulates channel function in rabbit heart. Biochem J 2004;377:357-366.
17. Donoso P, Sanchez G, Bull R, Hidalgo C. Modulation of cardiac ryanodine receptor activity by ROS and RNS. Front Biosci 2011;16:553-567.
18. Zima AV, Blatter LA. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006;71:310-321.
19. Eisner DA, Trafford AW, Diaz ME, Overend CL, O'Neill SC. The control of Ca release from the cardiac sarcoplasmic reticulum: regulation versus autoregulation. Cardiovasc Res 1998;38:589-604.
20. Belevych A, Kubalova Z, Terentyev D, Hamlin RL, Carnes CA, Gyorke S. Enhanced ryanodine receptor-mediated calcium leak determines reduced sarcoplasmic reticulum calcium content in chronic canine heart failure. Biophys J 2007;93:4083-4092.
21. Hasenfuss G, Pieske B. Calcium cycling in congestive heart failure. J Mol Cell Cardiol 2002;34:951-969.
22. Lou Q, Janardhan A, Efimov IR. Remodeling of calcium handling in human heart failure. Adv Exp Med Biol 2012;740:1145-1174.
23. Bers DM. Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda) 2006;21:380-387.
24. Pogwizd SM, Bers DM. Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med 2004;14:61-66.
25. Janse MJ. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res 2004;61:208-217.
26. Sossalla S, Fluschnik N, Schotola H, Ort KR, Neef S, Schulte T et al. Inhibition of elevated Ca2+/calmodulin-dependent protein kinase II improves contractility in human failing myocardium. Circ Res 2010;107:1150-1161.
27. Belevych AE, Terentyev D, Terentyeva R, Nishijima Y, Sridhar A, Hamlin RL et al. The relationship between arrhythmogenesis and impaired contractility in heart failure: role of altered ryanodine receptor function. Cardiovasc Res 2011;90:493-502.
28. Curran J, Brown KH, Santiago DJ, Pogwizd S, Bers DM, Shannon TR. Spontaneous Ca waves in ventricular myocytes from failing hearts depend on Ca2+-calmodulin-dependent protein kinase II. J Mol Cell Cardiol 2010;49:25-32.
29. Dincer UD. Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy Diabetes Metab Syndr Obes 2012;5:89-99.
30. Kalyanasundaram A, Lacombe VA, Belevych AE, Brunello L, Carnes CA, Janssen PM et al. Up-regulation of sarcoplasmic reticulum Ca2+ uptake leads to cardiac hypertrophy, contractile dysfunction and early mortality in mice deficient in CASQ2. Cardiovasc Res 2013;98:297-306.
31. van Oort RJ, Respress JL, Li N, Reynolds C, De Almeida AC, Skapura DG et al. Accelerated development of pressure overload-induced cardiac hypertrophy and dysfunction in an RyR2-R176Q knockin mouse model. Hypertension 2010;55:932-938.
32. Yamaguchi N, Takahashi N, Xu L, Smithies O, Meissner G. Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel. J Clin Invest 2007;117:1344-1353.
33. Zhang T, Guo T, Mishra S, Dalton ND, Kranias EG, Peterson KL et al. Phospholamban ablation rescues sarcoplasmic reticulum Ca2+ handling but exacerbates cardiac dysfunction in CaMKIIdC transgenic mice. Circ Res 2010;106:354-362.
34. Shannon TR, Pogwizd SM, Bers DM. Elevated sarcoplasmic reticulum Ca2+ leak in intact ventricular myocytes from rabbits in heart failure. Circ Res 2003;93:592-594.
35. Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM. Ca2+/calmodulin- dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res 2005;97:1314-1322.
36. Kubalova Z, Terentyev D, Viatchenko-Karpinski S, Nishijima Y, Gyorke I, Terentyeva R et al. Abnormal intrastore calcium signaling in chronic heart failure. Proc Natl Acad Sci USA 2005;102:14104-14109.
37. Bers DM. Ryanodine receptor S2808 phosphorylation in heart failure: smoking gun or red herring. Circ Res 2012;110:796-799.
38. Domeier TL, Blatter LA, Zima AV. Alteration of sarcoplasmic reticulum Ca2+ release termination by ryanodine receptor sensitization and in heart failure. J Physiol 2009; 587:5197-5209.
39. Venetucci LA, Trafford AW, O'Neill SC, Eisner DA. The sarcoplasmic reticulum and arrhythmogenic calcium release. Cardiovasc Res 2008;77:285-292.
40. Frank KF, Bolck B, Brixius K, Kranias EG, Schwinger RH. Modulation of SERCA: implications for the failing human heart. Basic Res Cardiol 2002;97(Suppl 1):I72-I78.
41. Pogwizd SM, Qi M, Yuan W, Samarel AM, Bers DM. Upregulation of Na+/Ca2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res 1999;85:1009-1019.
42. Mork HK, Sjaastad I, Sande JB, Periasamy M, Sejersted OM, Louch WE. Increased cardiomyocyte function and Ca2+ transients in mice during early congestive heart failure. J Mol Cell Cardiol 2007;43:177-186.
43. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009;54:1747-1762.
44. Baartscheer A, Schumacher CA, Belterman CN, Coronel R, Fiolet JW. SR calcium handling and calcium after-transients in a rabbit model of heart failure. Cardiovasc Res 2003;58:99-108.
45. Pogwizd SM, Schlotthauer K, Li L, YuanW, Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 2001;88: 1159-1167.
46. Curran J, Hinton MJ, Rios E, Bers DM, Shannon TR. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circ Res 2007;100:391-398.
47. Lakatta EG. Functional implications of spontaneous sarcoplasmic reticulum Ca2+ release in the heart. Cardiovasc Res 1992;26:193-214.
48. Colella M, Grisan F, Robert V, Turner JD, Thomas AP, Pozzan T. Ca2+ oscillation frequency decoding in cardiac cell hypertrophy: role of calcineurin/NFAT as Ca2+ signal integrators. Proc Natl Acad Sci USA 2008;105:2859-2864.
49. Anderson ME, Brown JH, Bers DM. CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 2011;51:468-473.
50. Stern MD, Capogrossi MC, Lakatta EG. Spontaneous calcium release from the sarcoplasmic reticulum in myocardial cells: mechanisms and consequences. Cell Calcium 1988;9:247-256.
51. Venetucci LA, Trafford AW, Eisner DA. Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: threshold sarcoplasmic reticulum calcium content is required. Circ Res 2007;100:105-111.
52. Hobai IA, O'Rourke B. Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation-contraction coupling in canine heart failure. Circulation 2001;103:1577-1584.
53. Desantiago J, Ai X, Islam M, Acuna G, Ziolo MT, Bers DM et al. Arrhythmogenic effects of b2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load. Circ Res 2008;102:1389-1397.
54. Belevych AE, Terentyev D, Terentyeva R, Ho HT, Gyorke I, Bonilla IM et al. Shortened Ca2+ signaling refractoriness underlies cellular arrhythmogenesis in a postinfarction model of sudden cardiac death. Circ Res 2012;110:569-577.
55. Benkusky NA, Weber CS, Scherman JA, Farrell EF, Hacker TA, John MC et al. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor. Circ Res 2007;101:819-829.
56. Maier LS, Zhang T, Chen L, DeSantiago J, Brown JH, Bers DM. Transgenic CaMKIIdC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release. Circ Res 2003;92:904-911.
57. Zhang T, Maier LS, Dalton ND, Miyamoto S, Ross J Jr, Bers DM et al. The dC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 2003;92:912-919.
58. Wu Y, Temple J, Zhang R, Dzhura I, Zhang W, Trimble R et al. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation 2002;106: 1288-1293.
59. van Oort RJ, McCauley MD, Dixit SS, Pereira L, Yang Y, Respress JL et al. Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 2010;122:2669-2679.
60. Sag CM, Wadsack DP, Khabbazzadeh S, Abesser M, Grefe C, Neumann K et al. Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure. Circ Heart Fail 2009;2:664-675.
61. Yuchi Z, Lau K, Van Petegem F. Disease mutations in the ryanodine receptor central region: crystal structures of a phosphorylation hot spot domain. Structure 2012;20: 1201-1211.
62. Terentyev D, Gyorke I, Belevych AE, Terentyeva R, Sridhar A, Nishijima Y et al. Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure. Circ Res 2008;103:1466-1472.
63. Gonzalez DR, Treuer AV, Castellanos J, Dulce RA, Hare JM. Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure. J Biol Chem 2010;285:28938-28945.
64. Xu L, Eu JP, Meissner G, Stamler JS. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 1998;279:234-237.
65. Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008;133:462-474.
66. Lukyanenko V, Viatchenko-Karpinski S, Smirnov A, Wiesner TF, Gyorke S. Dynamic regulation of sarcoplasmic reticulum Ca2+ content and release by luminal Ca2+-sensitive leak in rat ventricular myocytes. Biophys J 2001;81:785-798.
67. Kong MH, Fonarow GC, Peterson ED, Curtis AB, Hernandez AF, Sanders GD et al. Systematic review of the incidence of sudden cardiac death in the United States. J Am Coll Cardiol 2011;57:794-801.
68. Toischer K, Lehnart SE, Tenderich G, Milting H, Korfer R, Schmitto JD et al. K201 improves aspects of the contractile performance of human failing myocardium via reduction in Ca2+ leak from the sarcoplasmic reticulum. Basic Res Cardiol 2010;105:279-287.
69. Mochizuki M, Yano M, Oda T, Tateishi H, Kobayashi S, Yamamoto T et al. Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure. J Am Coll Cardiol 2007; 49:1722-1732.
70. Zhou Q, Xiao J, Jiang D, Wang R, Vembaiyan K, Wang A et al. Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release. Nat Med 2011;17:1003-1009.
71. Zhang R, Khoo MS, Wu Y, Yang Y, Grueter CE, Ni G et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 2005;11:409-417.
72. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001;104:2407-2411.
73. Hare JM, Mangal B, Brown J, Fisher C Jr, Freudenberger R, Colucci WS et al. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol 2008;51:2301-2309.
74. Miyamoto MI, del Monte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 2000;97:793-798.
75. del Monte F, Harding SE, Dec GW, Gwathmey JK, Hajjar RJ. Targeting phospholamban by gene transfer in human heart failure. Circulation 2002;105:904-907.
76. Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 2011;124:304-313.
77. Lyon AR, Bannister ML, Collins T, Pearce E, Sepehripour AH, Dubb SS et al. SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure. Circ Arrhythm Electrophysiol 2011;4: 362-372.
78. Tilemann L, Ishikawa K, Weber T, Hajjar RJ. Gene therapy for heart failure. Circ Res 2012;110:777-793.
79. Janczewski AM, Zahid M, Lemster BH, Frye CS, Gibson G, Higuchi Y et al. Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model. Cardiovasc Res 2004;62:468-480.
80. O'Donnell JM, Fields A, Xu X, Chowdhury SA, Geenen DL, Bi J. Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo. Am J Physiol Heart Circ Physiol 2008;295:H2483-H2494.